Revanaiah Yogisharadhya

Dr. Revanaiah Yogisharadhya

orcid

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2012 in Expert Review of Vaccines
Verified
Journal Article
Closed access
VBVeerakyathappa Bhanuprakash
Veerakyathappa Bhanuprakash
MHMadhusudan Hosamani
Madhusudan Hosamani
GVGnanavel Venkatesan
Gnanavel Venkatesan
Vinayagamurthy BalamuruganVinayagamurthy Balamurugan
Vinayagamurthy Balamurugan
RYRevanaiah Yogisharadhya
Revanaiah Yogisharadhya
RSRaj Kumar Singh
Raj Kumar Singh
The family Poxviridae includes several viruses of medical and veterinary importance. Global concerted efforts combined with an intensive mass-vaccination campaign with highly efficaceious live vaccine of vaccinia virus have led to eradication of smallpox. However, orthopoxviruses affecting domestic animals continue to cause outbreaks in several endemic countries. Different kinds of vaccines starting from conventional inactivated/attenuated to recombinant protein-based vaccines have been used for control of poxvirus infections. Live virus homologous vaccines are currently in use for diseases including capripox, parapox, camelpox and fowlpox, and these vaccines are highly effective in eliciting (with the exception of parapoxviruses) long-lasting immunity. Attenuated strains of poxviruses have been exploited as vectored vaccines to deliver heterologous immunogens, many of them being licensed for use in animals. Worthy of note are vaccinia virus, fowlpox virus, capripoxvirus, parapoxvirus and canary pox, which have been successfully used for developing new-generation vaccines targeting many important pathogens. Remarkable features of these vaccines are thermostability and their ability to engender both cellular and humoral immune responses to the target pathogens. This article updates the important vaccines available for poxviruses of livestock and identifies some of the research gaps in the present context of poxvirus research.

27 July 2010 in Transboundary and Emerging Diseases
Verified
Journal Article
Closed access
PDF file
VBV. Bhanuprakash
V. Bhanuprakash
GVG. Venkatesan
G. Venkatesan
Vinayagamurthy BalamuruganVinayagamurthy Balamurugan
Vinayagamurthy Balamurugan
MHM. Hosamani
M. Hosamani
RYRevanaiah Yogisharadhya
Revanaiah Yogisharadhya
RSR. K. Singh
R. K. Singh
Sheeppox and goatpox outbreaks occur often in India incurring huge economic loss to the small ruminant industry. This paper describes two sheeppox outbreaks, of which one occurred in an organized sheep breeding farm at Makhdoom (Uttar Pradesh), India, during 2007 and another in goats at the Central Institute of Research on Goats, Makhdoom (Uttar Pradesh), India during 2008. In the first outbreak, a local Muzaffarnagari sheep breed was affected (n = 477) with morbidity and mortality rates, respectively, of 100% and 53.9% accompanied by significant productivity losses. In the 2008 outbreaks, a small number of goats were affected without any mortality. The tissue and swabs collected from both the outbreaks were processed and inoculated onto Vero cells, and the causative agent of the outbreaks, capripox virus (CaPV), was isolated. The identity of the virus was confirmed as CaPV based on electron microscopy, experimental pathogenesis in sheep, capripox-specific conventional and real-time PCRs. Sequence analysis of the P32 envelope protein gene revealed that the causative agent of both outbreaks was confirmed as sheeppox virus (SPPV) implying SPPV infection not only in sheep but also goats in India.

18 November 2010 in Zoonoses and Public Health
Verified
Journal Article
Closed access
PDF file
VBV. Bhanuprakash
V. Bhanuprakash
GVG. Venkatesan
G. Venkatesan
Vinayagamurthy BalamuruganVinayagamurthy Balamurugan
Vinayagamurthy Balamurugan
MHM. Hosamani
M. Hosamani
RYRevanaiah Yogisharadhya
Revanaiah Yogisharadhya
RSR. K. Singh
R. K. Singh

1 December 2011 in Journal of Virological Methods
Verified
Journal Article
Closed access
DBDurlav Prasad Bora
Durlav Prasad Bora
GVG. Venkatesan
G. Venkatesan
VBV. Bhanuprakash
V. Bhanuprakash
Vinayagamurthy BalamuruganVinayagamurthy Balamurugan
Vinayagamurthy Balamurugan
MPM. Prabhu
M. Prabhu
RYRevanaiah Yogisharadhya
Revanaiah Yogisharadhya

1 December 2009 in Journal of Virological Methods
Verified
Journal Article
Closed access
VBV. Bhanot
V. Bhanot
Vinayagamurthy BalamuruganVinayagamurthy Balamurugan
Vinayagamurthy Balamurugan
VBV. Bhanuprakash
V. Bhanuprakash
GVG. Venkatesan
G. Venkatesan
ASA. Sen
A. Sen
RSR.K. Singh
R.K. Singh

1 May 2012 in Virus Genes
Verified
Journal Article
Closed access
PDF file
DBDurlav Prasad Bora
Durlav Prasad Bora
NBNagendra Nath Barman
Nagendra Nath Barman
SDSailendra Kumar Das
Sailendra Kumar Das
VBVeerakyathappa Bhanuprakash
Veerakyathappa Bhanuprakash
RYRevanaiah Yogisharadhya
Revanaiah Yogisharadhya
KBKamal Malla Bujarbaruah
Kamal Malla Bujarbaruah